Remitly Global (RELY): Firm Expects 28% YoY Growth
In early November, the company posted earnings for the third quarter of 2025, reporting earnings per share of $0.04, beating estimates by $0.01.
Insider Monkey Blog
Grindr (GRND): Firm Reaffirms 2025 Revenue Growth Outlook
Late last month, the company announced that it would cease engagement over a take-private offer from large shareholders Ray Zage and James Lu to buy the company for $18 per share...
Alkami Technology (ALKT): Jana Lauds Organic Top Line Growth
According to a report by news agency Reuters, activist investor Jana Partners took a stake in Alkami Technology, Inc. (NASDAQ:ALKT) in the third quarter.
Upstart Holdings (UPST): Firm Announces New Castlelake Deal
The fintech firm, founded in 2012, has originated about $48 billion in loans, a small share of the overall lending market.
Corcept Therapeutics (CORT): Analyst Says Shares Pricing in Growth, New Launch
On December 16, UBS analyst Ashwani Verma initiated coverage of Corcept Therapeutics Incorporated (NASDAQ:CORT) stock with a Neutral rating and $95 price target.
Clearwater Analytics Holdings (CWAN): Activist Investor Wants Share Price Boost
Latest reports, published by news agency Reuters, indicate that Thoma Bravo has made an offer for the company.
Wingstop (WING): RBC Highlights Growth, Long US Runway
On December 9, RBC Capital analyst Logan Reich raised the price target on Wingstop Inc. (NASDAQ:WING) stock to $350 from $300 and kept an Outperform rating on the shares.
Dutch Bros (BROS): KeyBanc Highlights Compelling Growth Story
On December 17, KeyBanc analyst Christopher Carril initiated coverage of Dutch Bros Inc. (NYSE:BROS) stock with an Overweight rating and $77 price target.
Coty Completes Wella Divestment to Refocus on Fragrances
Coty Inc. (COTY) is among the best fundamentally strong penny stocks to buy according to analysts. On December 19, Reuters reported that Coty Inc.
Denison Mines Forms Joint Ventures With Skyharbour
Denison Mines Corp. (NYSEAMERICAN:DNN) is among the best fundamentally strong penny stocks to buy according to analysts. On December 17, Denison Mines Corp.
Jefferies Sees Structural Strength but Limited Upside for UWM Holdings Corporation (UWMC)
UWM Holdings Corporation (NYSE:UWMC) is among the best fundamentally strong penny stocks to buy according to analysts.
Wall Street Keeps B2Gold Corp. (BTG) in Focus With Mixed Views
B2Gold Corp. (NYSEAMERICAN:BTG) is among the best fundamentally strong penny stocks to buy according to analysts. As of December 18, B2Gold Corp.
BlackBerry Limited (BB) Outperforms Estimates but RBC Sticks With Sector Perform
BlackBerry Limited (NYSE:BB) is among the best fundamentally strong penny stocks to buy according to analysts.
Is Recursion Pharmaceuticals, Inc. (RXRX) the Best Fundamentally Strong Penny Stock to Buy?
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best fundamentally strong penny stocks to buy according to analysts.
NIO Inc. (NIO) Holds Mixed Analyst Sentiment Despite Strong Median Upside Potential
NIO Inc. (NYSE:NIO) is among the best fundamentally strong penny stocks to buy according to analysts. As of December 19, NIO Inc.
Clarivate Plc (CLVT) Downgraded Amid Turnaround Challenges
Clarivate Plc (NYSE:CLVT) is among the best fundamentally strong penny stocks to buy according to analysts.
Cosan S.A. (CSAN) Gets Negative Outlook from Fitch as Leverage Remains High
Cosan S.A. (NYSE:CSAN) is among the best fundamentally strong penny stocks to buy according to analysts. On December 16, Fitch Ratings maintained Cosan S.A.
Bullish Analyst Sentiment on Fulcrum Therapeutics (FULC) Following Positive Updates from Phase 1b PIONEER Study
Following encouraging updates from the ongoing Phase 1b PIONEER study evaluating pociredir in sickle cell disease, analyst sentiment around Fulcrum Therapeutics, Inc.
Taysha Gene (TSHA) Hovers Around Its 52-Week High As It Continues to Advance Rett Syndrome Program
With strong 1-year returns and upside potential, Taysha Gene Therapies, Inc.
High Analyst Confidence on Palvella Therapeutics (PVLA) Following Encouraging Phase 2 Data for QTORIN Rapamycin
With strong 1-year returns and upside potential, Palvella Therapeutics, Inc.
Gossamer Bio (GOSS) Sees Strong Analyst Confidence Amid Seralutinib Progress and Upcoming PROSERA Data
Amid the company’s continued efforts to advance seralutinib across two late-stage pulmonary hypertension programs, analyst confidence in Gossamer Bio, Inc.
Strong REZOLVE-AA Study Results Drive Analyst Confidence in Nektar Therapeutics (NKTR)
Nektar Therapeutics (NASDAQ:NKTR) experienced a boost in analyst sentiment on December 16, 2025, following strong topline results from the 36-week induction period of the Phase...
Trevi Therapeutics (TRVI) Targets Next Phase of Growth with Leadership Change
On December 4, 2025, Trevi Therapeutics, Inc. (NASDAQ:TRVI) announced the appointment of David Hastings as Chief Financial Officer, effective January 6, 2026.
Analysts Remain Bullish on Seabridge Gold (SA) Amid KSM Project Progress
As of December 17, the stock is a consensus Buy with all analysts covering it assigning it a Buy or equivalent rating.
TD Cowen Initiates Coverage on RAPT Therapeutics (RAPT) with a “Buy”
On December 18, 2025, The Fly reported that TD Cowen initiated coverage of RAPT Therapeutics, Inc.
Analysts Bullish as Ventyx Biosciences (VTYX) Advances Its Clinical and Strategic Initiatives
As of December 18, 2025, 90% of analysts are bullish on Ventyx Biosciences, Inc. (NASDAQ:VTYX), setting a median price target of $14.00.
Analyst Sentiment Remains Bullish on CytomX Therapeutics (CTMX) Amid CX-2051 Therapy Progress
As of December 18, 2025, 90% of analysts are bullish on CytomX Therapeutics, Inc. (NASDAQ:CTMX), setting a median price target of $6.50.
H.C Wainwright and Citizens Raise PT on DBV Technologies (DBVT) Following Phase 3 VITESSE Trial Result
On December 17, 2025, H.C. Wainwright raised its price target on DBV Technologies S.A. (NASDAQ:DBVT) from $35 to $40, while reiterating a “Buy” rating, The Fly reported.
Compass Therapeutics’ (CMPX) Tovecimig Drives Strong Analyst Sentiment
On December 3, 2025, Compass Therapeutics, Inc. (NASDAQ:CMPX) saw Canaccord analyst John Newman initiate coverage of the stock with a “Buy” rating and a $10 price target.
15 Most Promising Mid-Cap Healthcare Stocks Under $50
Traditionally, healthcare stocks have been considered defensive, offering strong immunity to business cycles.
10 Stocks Jim Cramer Talked About
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the latest inflation report.
9 Best Fundamentally Strong Penny Stocks to Buy According to Analysts
Penny stocks often have a reputation for being volatile and risky, but some of these stocks are actually supported by strong fundamentals and growth potential.
10 AI Stocks on the Market’s Radar
Based on data from S&P Global Market Intelligence, data-center dealmaking surged to a record high through November this year, with more than 100 data center transactions during...
AST SpaceMobile (ASTS) Jumps 15% on Christmas Eve Launch of BlueBird 6
AST SpaceMobile saw its share prices jump by 15.03 percent on Friday to close at $75.84 apiece, tracking an overall market rally and placing bets ahead of the launch of its next...
Applied Digital (APLD) Climbs 16.5% Ahead of Earnings
Applied Digital extended its winning streak to a second day on Friday, surging 16.53 percent to close at $27.85 apiece as investors loaded positions early ahead of the results...
Carnival (CUK) Touches 5-Year High on Earnings Blowout, Upbeat Outlook
In an updated report, Carnival Corp.
Rocket Lab (RKLB) Soars 17.7% on Potential Billion-Dollar Contract with US SDA
Rocket Lab rallied for a second day on Friday, surging 17.69 percent to close at $70.52 apiece after bagging a potential billion-dollar contract to develop and produce satellites...
BioMarin (BMRN) Jumps 17.7% on $5-Billion Merger with Amicus
BioMarin Pharmaceutical extended its winning streak to a third straight day on Friday, surging 17.71 percent to finish at $61.15 apiece, as investors took heart from its expansion...
Ondas Holdings (ONDS) Soars 18% on New COO Appointment
Ondas Holdings jumped by 18.21 percent on Friday to close at $9.22 apiece as investors took heart from the creation of a key executive role and the appointment of a retired US...
CoreWeave (CRWV) Climbs 22.6% on ‘Buy’ From Citigroup
CoreWeave surged by 22.64 percent on Friday to close at $83 apiece as investors took path from an investment firm’s renewed coverage, but were generally optimistic for the stock...
Firefly (FLY) Soars 22.8% as Analyst Issues Optimistic Rating
In a market report, Keybanc issued a “sector weight” rating on shares of Firefly Aerospace Inc.
Amicus (FOLD) Flies to 52-Week High on $5-Billion BioMarin Merger
Amicus Therapeutics soared to a new 52-week high on Friday, jumping 30.21 percent to close at $14.18 apiece as investors gobbled up shares following announcements that it would...
Intuitive Machines (LUNR) Climbs 37.7% on Bullish Coverage, PT Upgrade
Intuitive Machines rallied for a second day on Friday, soaring 37.70 percent to close at $14.94 apiece as investors took heart from a bullish rating and price target from an investment...
Paychex, Inc. (NASDAQ:PAYX) Q2 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for your continued patience. Your meeting will begin shortly. If you need any assistance today, please press 0.
Winnebago Industries, Inc. (NYSE:WGO) Q1 2026 Earnings Call Transcript
Winnebago Industries, Inc. (NYSE:WGO) Q1 2026 Earnings Call Transcript December 19, 2025Winnebago Industries, Inc. beats earnings expectations.
Conagra Brands, Inc. (NYSE:CAG) Q2 2026 Earnings Call Transcript
Conagra Brands, Inc. (NYSE:CAG) Q2 2026 Earnings Call Transcript December 19, 2025Conagra Brands, Inc. beats earnings expectations.
Carnival Corporation & plc (NYSE:CCL) Q4 2025 Earnings Call Transcript
Carnival Corporation & plc (NYSE:CCL) Q4 2025 Earnings Call Transcript December 19, 2025Carnival Corporation & plc beats earnings expectations.
Lamb Weston Holdings, Inc. (NYSE:LW) Q2 2026 Earnings Call Transcript
Lamb Weston Holdings, Inc. (NYSE:LW) Q2 2026 Earnings Call Transcript December 19, 2025Lamb Weston Holdings, Inc. beats earnings expectations.
Carnival Corporation & plc (NYSE:CUK) Q4 2025 Earnings Call Transcript
Carnival Corporation & plc (NYSE:CUK) Q4 2025 Earnings Call Transcript December 19, 2025Carnival Corporation & plc beats earnings expectations.
Hedge Fund Resource Center
